/
We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key research and development, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals.
Margins and capital returns are both well above average: 29.63% operating margin, ROIC at 45.86%. Consistent with durable pricing power, though that alone doesn't make it a buy.
Revenue grew 4.0%, steady but not accelerating.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$4.09B
▲ +4.0% YoY
Net Income (TTM)
$875M
▲ +0.7% YoY
Op. Margin
29.40%
▼ -1.4pp YoY
ROIC
46.21%
▼ -1.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$794M
▼ -1.8% YoY
Op. Cash Flow (TTM)
$901M
▼ -1.3% YoY
Net Debt
$2.10B
Cash & Equiv.
$61M
5Y CAGR: +5.5%
5Y CAGR: +6.1%
Continue Research